Antitrust Antitrust

Vyera, accused of monopolizing drug, to face claims from more states, New York state lawyer says

By Richard Vanderford
  • 20 Mar 2020 14:16
  • 20 Mar 2020 14:16
Vyera Pharmaceuticals, accused by the Federal Trade Commission and New York of monopolizing the market for a toxoplasmosis drug, will soon face claims from several more states, a New York attorney said.

An amended complaint against the company, once run by jailed hedge fund manager Martin Shkreli, is expected to be filed by

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News